HuGE Literature Finder
Records
1
-
30
Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy. Genes & genomics 2022 May . Huh Yeon-Ju, Cho Sung-Yup, Cho Min-Sun, Lee Kyoung-Eun, Lee Joo- |
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial. International journal of cancer 2022 May . Koole Simone N, Schouten Philip C, Hauke Jan, Kluin Roel J C, Nederlof Petra, Richters Lisa K, Krebsbach Gabriele, Sikorska Karolina, Alkemade Maartje, Opdam Mark, Schagen van Leeuwen Jules H, Schreuder Henk W R, Hermans Ralph H M, de Hingh Ignace H J T, Mom Constantijne H, Arts Henriette J G, van Ham Maaike, van Dam Peter, Vuylsteke Peter, Sanders Joyce, Horlings Hugo M, van de Vijver Koen K, Hahnen Eric, van Driel Willemien J, Schmutzler Rita, Sonke Gabe S, Linn Sabine |
Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. International journal of radiation oncology, biology, physics 2021 Oct . Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer. Oncology 2021 Jun 1-8. Paik Hyun-June, Jung Youn Joo, Kim Dong Il, Lee Seungju, Jung Chang Shin, Kang Seok Kyung, Kim Jae-Joon, Oh So Yeon, Joo Ji Hyeon, Kim Hyun Y |
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer. NPJ breast cancer 2021 Mar 7 (1): 29. Kalra Maitri, Tong Yan, Jones David R, Walsh Tom, Danso Michael A, Ma Cynthia X, Silverman Paula, King Mary-Claire, Badve Sunil S, Perkins Susan M, Miller Kathy |
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Feb 56 26-34. Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M |
Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. European urology 2020 Aug . Schaid Daniel J, McDonnell Shannon K, FitzGerald Liesel M, DeRycke Lissa, Fogarty Zachary, Giles Graham G, MacInnis Robert J, Southey Melissa C, Nguyen-Dumont Tu, Cancel-Tassin Geraldine, Cussenot Oliver, Whittemore Alice S, Sieh Weiva, Ioannidis Nilah Monnier, Hsieh Chih-Lin, Stanford Janet L, Schleutker Johanna, Cropp Cheryl D, Carpten John, Hoegel Josef, Eeles Rosalind, Kote-Jarai Zsofia, Ackerman Michael J, Klein Christopher J, Mandal Diptasri, Cooney Kathleen A, Bailey-Wilson Joan E, Helfand Brian, Catalona William J, Wiklund Fredrick, Riska Shaun, Bahetti Saurabh, Larson Melissa C, Cannon Albright Lisa, Teerlink Craig, Xu Jianfeng, Isaacs William, Ostrander Elaine A, Thibodeau Stephen |
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer. International journal of cancer 2020 Jul . Zhang Juan, Yao Lu, Liu Yiqiang, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 (26): 3012-3023. Lambertini Matteo, Ameye Lieveke, Hamy Anne-Sophie, Zingarello Anna, Poorvu Philip D, Carrasco Estela, Grinshpun Albert, Han Sileny, Rousset-Jablonski Christine, Ferrari Alberta, Paluch-Shimon Shani, Cortesi Laura, Senechal Claire, Miolo Gianmaria, Pogoda Katarzyna, Pérez-Fidalgo Jose Alejandro, De Marchis Laura, Ponzone Riccardo, Livraghi Luca, Estevez-Diz Maria Del Pilar, Villarreal-Garza Cynthia, Dieci Maria Vittoria, Clatot Florian, Berlière Martine, Graffeo Rossella, Teixeira Luis, Córdoba Octavi, Sonnenblick Amir, Luna Pais Helena, Ignatiadis Michail, Paesmans Marianne, Partridge Ann H, Caron Olivier, Saule Claire, Del Mastro Lucia, Peccatori Fedro A, Azim Hatem |
Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy. Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database. Oncology 2020 Jan 1-4. Blanter Julia, Zimmerman Brittney, Tharakan Serena, Ru Meng, Cascetta Krystal, Tiersten A |
Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients. Translational oncology 2019 Dec 13 (2): 212-220. Gallardo-Rincón Dolores, Álvarez-Gómez Rosa María, Montes-Servín Edgar, Toledo-Leyva Alfredo, Montes-Servín Elizabeth, Michel-Tello David, Alamilla-García Gabriela, Bahena-González Antonio, Hernández-Nava Elizabeth, Fragoso-Ontiveros Veronica, Espinosa-Romero Raquel, Cetina-Pérez Luce |
Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients. Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers 2019 May 11 (6): . Vocka Michal, Zimovjanova Martina, Bielcikova Zuzana, Tesarova Petra, Petruzelka Lubos, Mateju Martin, Krizova Ludmila, Kotlas Jaroslav, Soukupova Jana, Janatova Marketa, Zemankova Petra, Kleiblova Petra, Novotny Jan, Konopasek Bohuslav, Chodacka Martina, Brychta Milan, Sochor Marek, Smejkalova-Musilova Denisa, Cmejlova Vlastimila, Kozevnikovova Renata, Miskarova Lenka, Argalacsova Sona, Stolarova Lenka, Lhotova Klara, Borecka Marianna, Kleibl Zden |
Prevalence of germline variants in inflammatory breast cancer. Cancer 2019 Apr . Rana Huma Q, Sacca Rosalba, Drogan Christine, Gutierrez Stephanie, Schlosnagle Emily, Regan Meredith M, Speare Virginia, LaDuca Holly, Dolinsky Jill, Garber Judy E, Overmoyer Beth |
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China. Breast cancer research and treatment 2019 Mar . Cao Wei, Xie Yuntao, He Yingjian, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Ouyang T |
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ. Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
BRCA1/BRCA2 Mutations Shaped by Ancient Consanguinity Practice in Southern Mediterranean Populations Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2963-2972. Belaiba Fadoua, Medimegh Imene, Bidet Yannick, Boussetta Sami, Baroudi Olfa, Mezlini Amel, Bignon Yves Jean, Benammar El gaaied Am |
Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer. Annals of diagnostic pathology 2018 Jun 36 28-30. Straub Melissa M, Podoll Mirna B, David Stephanie N, Wiesner Georgia L, Desouki Mohamed |
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality. Cancer treatment reviews 2018 May 67 34-44. Papadimitriou Marios, Mountzios Giannis, Papadimitriou Christos |
Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients. Medical oncology (Northwood, London, England) 2018 Apr 35 (6): 81. Kaur Raman Preet, Shafi Gowhar, Benipal Raja Paramjeet Singh, Munshi Anja |
Germline breast cancer susceptibility gene mutations and breast cancer outcomes. BMC cancer 2018 Mar 18 (1): 315. Wang Yong Alison, Jian Jhih-Wei, Hung Chen-Fang, Peng Hung-Pin, Yang Chi-Fan, Cheng Hung-Chun Skye, Yang An-Su |
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. The Lancet. Oncology 2018 Jan . Copson Ellen R, Maishman Tom C, Tapper Will J, Cutress Ramsey I, Greville-Heygate Stephanie, Altman Douglas G, Eccles Bryony, Gerty Sue, Durcan Lorraine T, Jones Louise, Evans D Gareth, Thompson Alastair M, Pharoah Paul, Easton Douglas F, Dunning Alison M, Hanby Andrew, Lakhani Sunil, Eeles Ros, Gilbert Fiona J, Hamed Hisham, Hodgson Shirley, Simmonds Peter, Stanton Louise, Eccles Diana |
The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study. International journal of breast cancer 2018 2018 1426369. Câmara Sara, Pereira Daniela, André Saudade, Mira Beatriz, Vaz Fátima, Oom Rodrigo, Marques José Carlos, Leal de Faria João, Rodrigues Dos Santos Catari |
Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients. Oncotarget 2017 Sep 8 (37): 61538-61550. Jeong Hae Min, Kim Ryong Nam, Kwon Mi Jeong, Oh Ensel, Han Jinil, Lee Se Kyung, Choi Jong-Sun, Park Sara, Nam Seok Jin, Gong Gyung Yup, Nam Jin Wu, Choi Doo Ho, Lee Hannah, Nam Byung-Ho, Choi Yoon-La, Shin Young K |
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates. Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac |
Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up. European journal of cancer care 2016 Oct . Dagan E, Gershoni-Baruch R, Kurolap A, Fried |
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine 2016 Oct 95 (40): e4975. Baretta Zora, Mocellin Simone, Goldin Elena, Olopade Olufunmilayo I, Huo Dezhe |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: